(PharmaNewsWire.Com, June 18, 2018 ) Molecular Cytogenetics is a branch of genetics devoted to the have a look at through molecular strategies of the shape and function of the cell constituents involved in heredity, along with a molecular analysis of chromosomes. It includes the use of numerous molecular strategies to visualize one or greater specific areas or a whole of the genome.
Molecular cytogenetics comprises of molecular biology and cytogenetics. Cytogenetics refers to the study of chromosomes and molecular cytogenetics further involves the analysis of genetic versions or alterations thru in-situ hybridization techniques. Molecular cytogenetics finds vital programs in the fields of biology and medicinal drug. Molecular cytogenetics researches the structural and purposeful employer of the chromosomes and its nucleus, genomic variations, expression and evolution, chromosomal abnormalities, in particular in medicinal and cancer-associated genetics.
In molecular cytogenetics, strategies consisting of fluorescence in situ hybridization (FISH) are carried out in which DNA probes are labeled with extraordinary colored fluorescent tags to visualize the complete genome or the most precise areas of the genome. Also, the virtual karyotyping method is executed in molecular cytogenetics to assess complete genome for the changes in the range of copies of the genome. FISH & GISH are one of the most reliable techniques for studying chromosomes.
The North America Molecular Cytogenetics market size turned into approx. USD 530 million in 2016. It is projected to grow at a CAGR of 10.5 % to attain USD 870 million by using 2021. It commands the largest market share of 34%.
Drivers and Restraints:
One of the most critical drivers for the molecular cytogenetics market is the increasing incidence of cancer the world over, which has pushed the demand for correct diagnostic solutions. Molecular cytogenetics is a beneficial tool in assessing the genetic background of pipeline capsules and might reliably is expecting the volume of the effect of the drug on the disease in question. Then again, inadequate insurance in scientific reimbursement plans is the top restraint on the global molecular cytogenetics market. Because of the growing adoption of molecular cytogenetics, that is probably to stay a key driver for the market in the coming years.
But, the steady government support to the development of the healthcare region internationally is likely to reduce the impact of this issue within the coming years.
With the aid of geography, the North America Molecular Cytogenetics marketplace has been classified into US and Canada. Currently, North America account for the biggest market share. It may be attributed to the rising incidences of cancer and growing wide variety of genetic disorders. It is in particular nasty closer to the little one population because they are at risk of the environmental elements which includes teratogens.
The main players of the market include Affymetrix, Inc., Agilent Technologies, Inc., Illumina, Inc., Abbott Laboratories, Bio-Rad Laboratories, Inc., Applied Spectral Imaging, Inc., and Thermo Fisher Scientific (Life Technologies), Inc.
Scope of the report
The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.
The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.
What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
